Document is current
Any future updates will be listed below
-
Authors
Barlowe, Trevor S.
Redd, Walker D.
Xue, Angela Z.
Kiran, Akshatha
McCallen, Justin D.
Eluri, Swathi
Reed, Craig C.
Dellon, Evan S.
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32 DK007634)
National Institutes of Health (T35 DK007386)
- License Information
-
More Information
Article History
Received: 19 April 2024
Accepted: 6 August 2024
First Online: 13 August 2024
Declarations
:
: Dr. Dellon is a consultant for Abbott, Abbvie, Adare/Ellodi, Aimmune, Akesobio, Alfasigma, ALK, Allakos, Amgen, Aqilion, Arena/Pfizer, Aslan, AstraZeneca, Avir, Biorasi, Calypso, Celgene/Receptos/BMS, Celldex, Eli Lilly, EsoCap, Eupraxia, Dr. Falk Pharma, Ferring, GSK, Gossamer Bio, Holoclara, Invea, Knightpoint, Landos, LucidDx, Morphic, Nexstone Immunology/Uniquity, Nutricia, Parexel/Calyx, Phathom, Regeneron, Revolo, Robarts/Alimentiv, Salix, Sanofi, Shire/Takeda, Target RWE, Upstream Bio, has received research funding from Adare/Ellodi, Allakos, Arena/Pfizer, AstraZeneca, Eupraxia, Ferring, GSK, Meritage, Miraca, Nutricia, Celgene/Receptos/BMS, Regeneron, Revolo, Shire/Takeda, and has received education grants from Allakos, Banner, Holoclara, and Invea. None of the other authors report any potential conflicts of interest with this study.
